한글목차

세계 폐암 수술 시장의 미래는 병원, 암 전문 의료 센터, 외래 수술 센터 시장에 기회가 있어 유망한 것으로 평가되고 있습니다. 세계 폐암 수술 시장은 2025년부터 2031년까지 3.4%의 CAGR로 2031년까지 약 59억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 폐암 발생률 증가, 최소침습 수술에 대한 소비자 선호도 증가, 대기 오염 수준 증가 등입니다.

• Lucintel의 예측에 따르면, 유형별로는 수술용 장비가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 최종 용도 부문에서는 외래 수술 센터가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 큰 지역으로 남아 있습니다.

폐암 수술 시장의 전략적 성장 기회

폐암 수술 시장은 기술 발전, 환자 수요의 변화, 정밀 의료에 대한 관심 증가로 인해 많은 전략적 성장 기회를 가지고 있습니다. 다양한 용도는 기술 혁신과 시장 확대를 위한 투자 기회를 제공하고 환자의 복지에 긍정적인 영향을 미칠 것입니다.

• 첨단 수술 기술 개발 : 폐암 수술의 정확성, 제어 및 효과는 첨단 수술 기술의 개발 및 통합을 통해 개선될 수 있습니다. 최소침습 수술, 실시간 내비게이션 등을 가능하게 하는 로봇 시스템 및 첨단 영상 기술의 사용은 더 나은 수술 결과를 가져다 줄 수 있습니다. 이러한 투자는 더 나은 치료 옵션을 제공하고 수술 옵션을 증가시킴으로써 시장 성장을 촉진할 것으로 보입니다.
• 최소침습적 시술의 확대 : 회복 시간 단축, 합병증 감소, 환자 편의성을 개선한 수술에 대한 수요가 증가함에 따라 최소침습적 접근법의 활용이 증가하고 있습니다. 이는 개복 수술에 대한 효율적인 치료 대안을 제공함과 동시에 치료 과정에서 환자의 전반적인 경험을 개선함으로써 시장 성장에 기여하고 있습니다.
• 개인화 의료의 통합 : 개인화 의료는 모든 형태의 수술을 진행하기 전에 개인의 특성을 고려할 수 있기 때문에 가장 효과적인 치료를 보장합니다. 이 시스템은 종양의 특정 특징과 같이 다른 것과는 다른 고유한 요소에 초점을 맞춥니다. 맞춤형 의료의 통합은 보다 집중적이고 효과적인 치료를 가능하게함으로써 시장 성장을 촉진할 것입니다.
• 수술 후 관리 및 재활 강화 : 수술 후 관리 및 재활 프로그램의 개선은 환자의 조기 치유와 치료 결과를 개선하는 데 기여합니다. 이러한 기회에는 통증 관리, 지지요법 및 재활 전략의 발전이 포함되며, 이는 삶의 질 향상과 이환율 감소로 이어질 수 있습니다. 결과적으로 수술 후 치료에 대한 투자는 환자의 회복 및 전반적인 건강과 관련된 중요한 요인을 해결함으로써 시장 확대를 촉진할 것으로 보입니다.
• 신흥 시장 진출 : 신흥 시장 진출은 암 치료 인프라 구축과 첨단 치료 접근성 개선에 대한 투자로 인해 시장 성장의 기회가 될 수 있습니다. 이는 수술에 사용되는 혁신적인 기술을 통해 치료 옵션을 증가시켜 시장 성장을 촉진하고, 해당 지역의 치료 품질을 향상시킬 수 있습니다.

첨단 수술 장비 개발, 최소침습 기술, 맞춤형 의료의 통합, 더 나은 수술 후 관리, 신흥 시장 진출 등 폐암 수술 시장의 전략적 기회를 활용하면 시장 점유율을 크게 확대할 수 있습니다. 이를 통해 기술 혁신, 환자 결과 개선, 폐암 치료의 미래 혁신으로 이어질 수 있는 큰 잠재력이 있습니다.

폐암 수술 시장의 촉진요인 및 과제

폐암 수술 시장의 발전은 성장에 영향을 미치는 다양한 촉진요인과 과제에 의해 형성되고 있습니다. 기술 발전, 최소침습 수술에 대한 수요 증가, 맞춤형 의료의 부상 등이 주요 촉진요인으로 꼽힙니다. 그러나 높은 비용, 복잡한 수술, 불평등한 의료 접근성 등은 이 분야에 큰 도전이 되고 있습니다. 이러한 요인을 이해하는 것은 이 역동적인 환경에서 성공하기 위해 매우 중요합니다.

폐암 수술 시장을 주도하는 요인

1. 기술 발전 : 기술 혁신으로 폐암 수술의 정확도가 향상되어 치료 결과의 개선과 회복 시간 단축으로 이어지고 있습니다. 로봇 보조 시스템 및 첨단 영상 기술은 최소침습 수술을 지원하고 수술 중 실시간 안내를 제공합니다. 이러한 발전은 환자 경험을 개선하고 폐암 수술의 효과와 접근성을 향상시키면서 시장의 급격한 성장에 기여하고 있습니다.

2. 최소침습 수술에 대한 수요 : 최소침습 수술에 대한 수요가 증가함에 따라 비디오 보조 흉강경 수술(VATS) 및 로봇 보조 수술과 같은 기술이 채택되고 있습니다. 이러한 수술은 통증 감소, 회복 시간 단축, 합병증 감소 등 여러 가지 장점을 가지고 있으며, 이 모든 것이 시장 성장의 원동력이 되고 있습니다. 환자들이 덜 침습적인 옵션을 선호함에 따라 이러한 수술로의 전환은 계속 확대되고 있습니다.

3. 개인맞춤의료의 발전 : 개인의 유전적, 분자적 프로필에 따라 치료법을 조정하는 개인맞춤의료는 폐암 수술의 전망에 혁명을 불러일으키고 있습니다. 이 접근법은 각 환자의 특정 요구에 초점을 맞춰 외과적 개입의 효과를 향상시키는 접근법입니다. 맞춤형 치료 계획을 제공함으로써 맞춤형 의료는 전반적인 수술 결과를 개선하고 시장 성장을 뒷받침하고 있습니다.

4. 의료 인프라의 확장 : 의료 인프라의 확장은 폐암 수술 시장의 성장에 중요한 역할을 하고 있습니다. 암 치료 시설에 대한 투자와 첨단 치료의 가용성은 첨단 수술 기법에 대한 광범위한 접근을 가능하게 합니다. 특히 신흥국 시장에서의 의료 인프라 개발은 혁신적인 수술 기술의 채택을 촉진하고 치료 옵션을 개선하는 데 기여합니다.

5. 더 나은 환자 결과의 중요성 : 수술 중과 수술 후 관리 모두에서 환자의 결과를 개선하는 것이 점점 더 중요해지고 있습니다. 수술 후 재활 및 회복 기술의 발전은 환자의 생존율과 삶의 질을 향상시키고 있습니다. 그 결과, 전반적인 치료 결과를 개선할 수 있는 효과적이고 혁신적인 수술에 대한 수요가 증가하고 있습니다.

폐암 수술 시장의 도전 과제

1. 높은 초기 비용 : 폐암 수술 시장이 직면한 주요 과제 중 하나는 첨단 수술 기술과 치료법의 높은 비용입니다. 특히 자원이 부족한 환경에서는 이러한 비용이 엄청날 수 있으며, 접근성과 경제성을 제한할 수 있습니다. 비용 장벽을 해결하고 비용 효율적인 솔루션을 찾는 것은 시장 침투를 확대하고 첨단 치료에 대한 접근성을 개선하는 데 있어 매우 중요합니다.

2. 수술 절차의 복잡성 : 폐암 수술은 매우 복잡하고 전문적인 기술과 지식이 필요합니다. 의료진은 고도의 훈련과 교육이 필요하기 때문에 특히 의료서비스가 부족한 지역에서는 이러한 수술의 이용이 제한될 수 있습니다. 수술의 복잡성으로 인해 장비와 수술팀 준비에 어려움이 발생하여 환자가 이러한 중요한 치료를 받을 수 있는지에 영향을 미칠 수 있습니다.

3. 의료 접근성 격차 : 폐암 수술에 대한 접근성에는 의료 격차가 존재하며, 지역 및 집단별로 고급 수술 치료에 대한 접근성이 제한되어 있습니다. 이러한 격차는 혁신적인 치료법의 광범위한 채택을 방해하고 불평등한 치료 결과를 초래할 수 있습니다. 이러한 지역적 격차를 해소하고 의료 자원을 공평하게 배분하는 것은 시장 확대와 전 세계 치료 결과 개선에 필수적입니다.

폐암 수술 시장은 주로 기술 발전, 최소침습 수술에 대한 수요 증가, 맞춤형 의료의 성장, 의료 인프라 확대, 환자 결과 개선에 대한 강조에 의해 주도되고 있습니다. 그러나 높은 비용, 수술의 복잡성, 의료 접근성 격차 등의 문제는 시장 역학에 지속적으로 영향을 미치고 있습니다. 폐암 수술의 발전과 시장 기회를 확대하기 위해서는 시장 촉진요인을 활용하면서 이러한 문제를 해결하는 것이 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 폐암 수술 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년에서 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 폐암 수술 시장 동향(2019-2024년)과 예측(2025-2031년)
• 폐암 수술 세계 시장, 제품 유형별
  • 외과용 기기
  • 내시경 수술 장비
  • 모니터링 또는 가시화 장비
• 세계의 폐암 수술 시장, 수술별
  • 로봇 수술
  • 개흉술
  • 비디오 지원 수술
  • 경피 수술
  • 기관지내 수술
• 세계의 폐암 수술 시장, 최종 용도별
  • 병원
  • 전문 암케어 센터
  • 외래 수술 센터
  • 기타

제4장 2019년에서 2031년까지 시장 동향과 예측 분석, 지역별

• 폐암 수술 시장, 지역별
• 북미의 폐암 수술 시장
• 유럽의 폐암 수술 시장
• 아시아태평양의 폐암 수술 시장
• 기타 지역의 폐암 수술 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 폐암 수술 시장 성장 기회, 제품 유형별
  • 세계의 폐암 수술 시장 성장 기회, 수술별
  • 세계의 폐암 수술 시장 성장 기회, 최종 용도별
  • 세계의 폐암 수술 시장 성장 기회, 지역별
• 세계의 폐암 수술 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 폐암 수술 시장 능력 확대
  • 세계의 폐암 수술 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend

영문목차

The future of the global lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.9 billion by 2031 with a CAGR of 3.4% from 2025 to 2031. The major drivers for this market are the rising occurrence of lung cancer, increasing consumer preference for minimally invasive surgeries, and increasing air pollution levels.

• Lucintel forecasts that, within the type category, surgical device is expected to witness the highest growth over the forecast period.
• Within the end-use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lung Cancer Surgery Market

Technological advancements, evolving patient requirements, and innovations in surgical techniques are key factors driving emerging trends in the lung cancer surgery market. These trends are enabling better patient outcomes while reducing the impacts on patients undergoing treatment.

• Robotic-Assisted Surgery: Robotic-assisted surgery enhances accuracy, precision, and control while minimizing scars, allowing for minimal incision procedures. This leads to reduced postoperative pain, shorter recovery times, and fewer complications. Additionally, robotic systems enable surgeons to perform complex operations with greater accuracy, improving patient outcomes and expanding the range of available treatments.
• Minimally Invasive Techniques: Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS), are becoming increasingly common due to their benefits, including shorter healing times and fewer post-surgery complications. Smaller incisions made during these procedures reduce pain and enhance patient comfort. Patients experience quicker recovery, enabling them to return to daily activities faster.
• Integration of Advanced Imaging: Advanced imaging technologies, such as high-definition CT scans, PET scans, and intraoperative MRI, improve tumor localization and staging accuracy. These technologies contribute to better preoperative planning and provide real-time navigation during surgery, resulting in more precise interventions. The integration of innovative imaging modalities has significantly enhanced surgical outcomes.
• Personalized Medicine and Targeted Therapies: Personalized medicine involves creating individualized treatment plans based on a patient's unique genetic or molecular profile. Unlike standard approaches targeting general cancer mutations or pathways, targeted therapies are designed to address specific ones. The combination of personalized medicine and surgery is transforming treatment methods, providing more effective care tailored to the patient's specific needs.
• Enhanced Postoperative Care: Advanced postoperative care strategies, including sophisticated pain management techniques and rehabilitation programs, promote better recovery outcomes. Focused on minimizing complications, managing pain, and supporting overall well-being, these strategies are increasing patients' quality of life. They also facilitate faster recovery and contribute to full recovery after lung cancer surgery.

Significant advancements in lung cancer surgery, such as robotic-assisted surgeries, minimally invasive techniques, advanced imaging systems, personalized medicine, and improved postoperative care, are transforming the field. These trends improve surgical precision, enhance patient outcomes, and increase the effectiveness of treatments, thus reshaping the landscape of lung cancer surgery.

Recent Developments in the Lung Cancer Surgery Market

Recent advances in lung cancer surgery have been driven by technological advancements, improved techniques, and evolving patient care models. These improvements enhance the accuracy and effectiveness of surgical interventions, leading to better management of lung cancer cases.

• Adoption of Robotic-Assisted Surgery: Robotic-assisted surgery has revolutionized lung cancer treatment by providing surgeons with greater precision and control. Robotic systems enable less invasive operations with more accuracy, reducing the need for large incisions and minimizing post-operative pain. This innovation leads to faster healing, fewer complications, and improved surgical outcomes, benefiting both patients and healthcare providers.
• Integration of Advanced Imaging Technologies: New imaging technologies, such as HDCT scans, PET scans, and intraoperative MRIs, have improved tumor detection accuracy and localization efficiency. These methods enhance preoperative planning and provide real-time guidance during surgery, ensuring that interventions are precise and effective. The use of advanced imaging is increasing surgical accuracy, leading to better patient outcomes.
• Expansion of Minimally Invasive Techniques: Lung cancer surgery is being transformed by the expansion of minimally invasive techniques, such as Video-Assisted Thoracoscopic Surgery (VATS) and robotic-assisted thoracic surgeries. These techniques involve smaller incisions that cause less disruption to surrounding tissues, resulting in shorter healing times and fewer infections or complications. The shift from open procedures to less invasive methods improves patient comfort and promotes quicker recovery, making these procedures a preferred choice for both surgeons and patients.
• Advances in Personalized Medicine: Personalized medicine is significantly impacting lung cancer surgery by offering treatment plans tailored to individual patient profiles. Genetic and molecular profiling helps identify specific mutations and cancer characteristics, enabling targeted drug therapies in combination with surgical interventions. This approach makes treatment more effective for each patient's unique condition, resulting in more personalized and efficient care.
• Focus on Enhanced Postoperative Care: Postoperative care has been enhanced to support rapid recovery in lung cancer patients. This includes advanced pain management techniques, rehabilitative programs, and supportive care policies aimed at reducing complications and speeding up the healing process. These improvements enhance patients' overall health and quality of life after surgery, contributing to higher success rates during recovery.

The latest developments in lung cancer surgery, including robotic-assisted surgery, advanced imaging technologies, minimally invasive techniques, personalized medicine, and enhanced postoperative care, are driving significant improvements in the field. These advancements increase surgical precision and improve patient outcomes, shaping the future of lung cancer treatment.

Strategic Growth Opportunities for Lung Cancer Surgery Market

The lung cancer surgical market holds many strategic growth opportunities due to technological advancements, changing patient demands, and an increased emphasis on precision medicine. Various applications provide openings for innovation and investment toward market expansion, which would positively impact patients' welfare.

• Development of Advanced Surgical Technologies: The precision, control, and effectiveness of lung cancer surgeries are improved by the development and integration of advanced surgical technologies. The surgical results achieved are better due to the use of robotic systems and advanced imaging technologies, which allow for minimally invasive procedures and real-time navigation, among other benefits. These investments will drive market growth by offering better treatment alternatives and more surgical options.
• Expansion of Minimally Invasive Techniques: There is increasing demand for procedures with shorter recovery times, fewer complications, and greater patient comfort, which is pushing the use of minimally invasive approaches. This opportunity helps grow the market by providing efficient substitutes to open surgeries while also improving the overall patient experience during the treatment process.
• Integration of Personalized Medicine: Personalized medicine allows for consideration of individual characteristics before proceeding with any form of surgery, thus ensuring the most effective treatment. This system focuses on unique factors, such as the specific characteristics of a tumor, which differentiate it from others. The integration of personalized medicine drives market growth by enabling more focused and effective treatments.
• Enhancement of Postoperative Care and Rehabilitation: Improved postoperative care and rehabilitation programs contribute to faster healing and enhanced outcomes for patients. This opportunity includes advances in pain management, supportive care, and rehabilitation strategies, which lead to improved quality of life and reduced morbidity. Consequently, investing in postoperative care promotes market expansion by addressing key factors related to patient recovery and overall health.
• Expansion into Emerging Markets: Expansion into emerging markets presents an opportunity for market growth as these regions invest in improving cancer care infrastructure and access to advanced treatments. This will ensure more treatment options through innovative technologies used during surgical operations, which, in turn, drives market growth and improves treatment quality in these regions.

Leveraging strategic opportunities in the lung cancer surgery market, such as the development of advanced surgical tools, minimally invasive techniques, integration of personalized medicine, better postoperative care, and expansion into emerging markets, can lead to a significant increase in market share. By doing so, there is enormous potential for innovation, improved patient outcomes, and a transformative future for lung cancer treatments.

Lung Cancer Surgery Market Driver and Challenges

The development of the lung cancer surgery market is shaped by various drivers and challenges that influence its growth. Technological advancements, the increasing demand for minimally invasive procedures, and the rise of personalized medicine are some of the key drivers. However, high costs, complex surgical procedures, and unequal access to healthcare pose significant challenges to the sector. Understanding these factors is crucial for achieving success in this dynamic environment.

Factors Driving the Lung Cancer Surgery Market:

1. Technological Advancements: Technological innovations are making lung cancer surgeries more precise, which leads to improved outcomes and faster recovery times. Robotic-assisted systems and advanced imaging technologies support minimally invasive procedures and provide real-time guidance during surgeries. These advancements enhance patient experiences and contribute to the rapid growth of the market, as they improve the effectiveness and accessibility of lung cancer surgery.

2. Demand for Less Invasive Procedures: The growing demand for minimally invasive surgery has led to the adoption of techniques such as Video-Assisted Thoracoscopic Surgery (VATS) and robotic-assisted surgery. These procedures offer several advantages, including reduced pain, quicker recovery times, and fewer complications, all of which drive the market's growth. As patients increasingly prefer less invasive options, the shift toward these techniques continues to grow.

3. Advances in Personalized Medicine: Personalized medicine, which tailors treatments based on an individual's genetic and molecular profile, is revolutionizing the lung cancer surgery landscape. This approach enhances the effectiveness of surgical interventions by targeting the specific needs of each patient. By offering customized treatment plans, personalized medicine improves overall surgical outcomes and supports market growth.

4. Healthcare Infrastructure Expansion: The expansion of healthcare infrastructure plays a crucial role in the growth of the lung cancer surgery market. Investments in cancer care facilities and the availability of advanced treatments enable broader access to cutting-edge surgical techniques. The development of healthcare infrastructure, especially in emerging markets, drives the adoption of innovative surgical technologies and contributes to improved treatment options.

5. Emphasis on Better Patient Outcomes: There is a growing emphasis on improving patient outcomes, both during surgery and in post-operative care. Advancements in post-surgery rehabilitation and recovery techniques increase the chances of survival and quality of life for patients. As a result, there is a greater demand for effective and innovative surgical procedures that can lead to better overall treatment results.

Challenges in the Lung Cancer Surgery Market:

1. High Initial Costs: One of the main challenges facing the lung cancer surgery market is the high cost of advanced surgical technologies and treatments. These costs can be prohibitive, particularly in resource-constrained settings, limiting accessibility and affordability. Addressing cost barriers and finding cost-effective solutions will be critical for expanding market penetration and improving access to advanced treatments.

2. Complexity of Surgical Procedures: Lung cancer surgeries are highly complex and require specialized skills and expertise. The need for advanced training and education for healthcare professionals can limit the availability of these procedures, particularly in underserved areas. The complexity of the surgeries also creates challenges in terms of equipment and surgical team readiness, which may affect patient access to these critical treatments.

3. Disparities in Healthcare Access: Healthcare disparities exist in terms of access to lung cancer surgeries, with some regions or populations having limited access to advanced surgical treatments. These disparities hinder the broader adoption of innovative procedures, leading to unequal treatment outcomes. Addressing these regional differences and ensuring fair distribution of healthcare resources will be essential to expanding market reach and improving global treatment outcomes.

The lung cancer surgery market is primarily driven by technological advancements, the rising demand for minimally invasive procedures, the growth of personalized medicine, the expansion of healthcare infrastructure, and an emphasis on improving patient outcomes. However, challenges such as high costs, the complexity of surgical procedures, and disparities in healthcare access continue to impact market dynamics. Addressing these challenges while capitalizing on the market drivers will be essential for advancing lung cancer surgery practices and expanding market opportunities.

List of Lung Cancer Surgery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies lung cancer surgery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include-

• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend

Lung Cancer Surgery by Segment

The study includes a forecast for the global lung cancer surgery market by product type, surgery, end use, and region.

Lung Cancer Surgery Market by Product Type [Analysis by Value from 2019 to 2031]:

• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment

Lung Cancer Surgery Market by Surgery [Analysis by Value from 2019 to 2031]:

• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery

Lung Cancer Surgery Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others

Lung Cancer Surgery Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Lung Cancer Surgery Market

Recent developments in lung cancer surgery have been characterized by significant advancements in surgical techniques, technology, and patient management strategies across various countries. These developments are improving the quality of treatments, leading to better patient outcomes and fostering innovation. This brief provides an overview of some key changes that have taken place within the lung cancer surgery market in countries such as the United States, China, Germany, India, and Japan.

• United States: Innovations in American lung cancer surgery include increased use of minimally invasive procedures like robotic-assisted surgery and video-assisted thoracoscopic surgery (VATS). These methods have several advantages over traditional open surgeries, including shorter recovery times and fewer complications. Additionally, there has been a surge in targeted therapies and personalized medicine that incorporates genomic data in planning surgeries. Another notable advancement is the development of new imaging technologies, such as high-definition CT scans and PET scans, which provide improved preoperative staging and intra-operative navigation for more precise and effective interventions.
• China: China has made remarkable strides in lung cancer surgery through the adoption of advanced surgical technologies and minimally invasive approaches. This expansion includes the use of robotic-assisted surgery, which allows for more precise and controlled procedures. Improving surgical outcomes is also being achieved through multidisciplinary efforts that bring together oncologists, radiologists, surgeons, and other specialists. Additionally, the improvement of postoperative care systems and rehabilitation has led to faster recovery rates and fewer complications following surgeries. These efforts are aimed at improving access to modern treatment modalities and, as a result, enhancing prognosis for patients diagnosed with lung cancer.
• Germany: Germany is leading in cutting-edge surgical technologies and techniques for the treatment of lung cancer patients. One recent development is the use of augmented reality during intra-surgical procedures, such as the introduction of intraoperative MRI, which increases accuracy during operations. The country emphasizes minimally invasive options, particularly robotic-assisted thoracic surgery, which ensures quicker recovery and reduced postoperative pain. Germany's investment in research and innovation in cancer treatment has resulted in significant improvements in surgical procedures. Additionally, the nation's cancer care programs include extensive training for physicians across various specialties.
• India: In India, recent developments in lung cancer surgery are marked by improved access to advanced surgical technologies, largely due to better training for healthcare professionals. Both the public and private sectors in India are driving the demand for minimally invasive techniques, including VATS and robotic-assisted surgery. There is also a concerted effort to improve cancer care infrastructure, including the establishment of specialized cancer centers equipped with the latest imaging technology. Additionally, there is a growing focus on improving patient outcomes through enhanced postoperative care and rehabilitation programs. These advances are helping to increase treatment options and improve outcomes in cases where the lungs are affected by cancer.
• Japan: Japan has made significant strides in lung cancer surgery due to the use of advanced surgical techniques and technologies. Robotic-assisted thoracic surgery, which is at the forefront in Japan, has brought greater precision and more minimally invasive options for patients. Recent developments focus on improving surgical outcomes through high-definition imaging and real-time navigation systems. Japan has also integrated personalized medicine and targeted therapies into surgical methods, driven by the nation's strong commitment to cancer treatment research and development. In Japan, early detection and minimally invasive surgery are contributing to higher survival rates and improved quality of life for patients with lung cancer.

Features of the Global Lung Cancer Surgery Market

Market Size Estimates: Lung cancer surgery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lung cancer surgery market size by product type, surgery, end use, and region in terms of value ($B).

Regional Analysis: Lung cancer surgery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, surgeries, end uses, and regions for the lung cancer surgery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lung Cancer Surgery Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Lung Cancer Surgery Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Lung Cancer Surgery Market by Product Type
  • 3.3.1: Surgical Devices
  • 3.3.2: Endosurgical Equipment
  • 3.3.3: Monitoring or Visualizing Equipment
• 3.4: Global Lung Cancer Surgery Market by Surgery
  • 3.4.1: Robotic Surgery
  • 3.4.2: Thoracotomy
  • 3.4.3: Video Assisted Surgery
  • 3.4.4: Percutaneous Surgery
  • 3.4.5: Endobronchial Surgery
• 3.5: Global Lung Cancer Surgery Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Cancer Care Centers
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Lung Cancer Surgery Market by Region
• 4.2: North American Lung Cancer Surgery Market
  • 4.2.1: North American Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.2.2: North American Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Lung Cancer Surgery Market
  • 4.3.1: European Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.3.2: European Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Lung Cancer Surgery Market
  • 4.4.1: APAC Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.4.2: APAC Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Lung Cancer Surgery Market
  • 4.5.1: ROW Lung Cancer Surgery Market by Product Type: Surgical Devices, Endosurgical Equipment, and Monitoring or Visualizing Equipment
  • 4.5.2: ROW Lung Cancer Surgery Market by End Use: Hospitals, Specialty Cancer Care Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Lung Cancer Surgery Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Lung Cancer Surgery Market by Surgery
  • 6.1.3: Growth Opportunities for the Global Lung Cancer Surgery Market by End Use
  • 6.1.4: Growth Opportunities for the Global Lung Cancer Surgery Market by Region
• 6.2: Emerging Trends in the Global Lung Cancer Surgery Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Lung Cancer Surgery Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lung Cancer Surgery Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Scanlan International
• 7.2: Ethicon Endo Surgery
• 7.3: Covidien
• 7.4: Trokamed
• 7.5: Angiodynamics
• 7.6: Richard Wolf
• 7.7: BSD Medical
• 7.8: Siemens Healthcare
• 7.9: Accuray
• 7.10: Neomend